Fundraising FoxFuse Oncology
Greensboro, US · Founded 2021 · 2 known investors
Find your way into Fuse Oncology
Sign up to find every way you can get introduced to Fuse Oncology
- Your email: who you already know at Fuse Oncology, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Fuse Oncology team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Fuse Oncology offers an AI-based software suite for radiation oncology that handles treatment planning, prior authorization, clinical documentation, charge-capture billing, and analytics. It serves clinicians and administrators at hospitals and cancer treatment facilities, aiming to shorten the time from consult to treatment.
Founders & leadership
Investors · 2
How we know: First Trust Capital Partners's portfolio page · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.8M disclosed across 2 rounds · 2021–2023
▶$8.9MraisedApr 2023 · 20 investors · Other Health CareRule 506(b)
- John MillerDirector
- Jay BrennanDirector
- Benjamin SintayExecutive Officer
- John StriderExecutive Officer
- James BaulerExecutive Officer, Director
- David WiantExecutive Officer
- Offering amount
- $9.7M
- Amount sold
- $8.9M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3MraisedMay 2022 · 18 investors · Other Health CareRule 506(b)
- John MillerDirector
- John StriderExecutive Officer
- Benjamin SintayExecutive Officer
- Jay BrennanDirector
- James BaulerExecutive Officer
- David WianttExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $25K
- Proceeds to insiders
- $150K
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Fuse Oncology do?
- Fuse Oncology offers an AI-based software suite for radiation oncology that handles treatment planning, prior authorization, clinical documentation, charge-capture billing, and analytics. It serves clinicians and administrators at hospitals and cancer treatment facilities, aiming to shorten the time from consult to treatment.
- Who are Fuse Oncology's investors?
- Fuse Oncology's investors include First Trust Capital Partners, First Launch Capital.
- How much funding has Fuse Oncology raised?
- Fuse Oncology has disclosed $11.8M raised across 2 rounds.
- Where is Fuse Oncology headquartered?
- Fuse Oncology is headquartered in Greensboro, US.